|
Thursday, February 15, 2007:
7:30 – 8:30 a.m. Breakfast and Registration
8:30 – 8:45 a.m. Seating
THROMBOSIS PREVENTION:
8:45 a.m. Welcome: Arthur A. Sasahara, MD
8:55 a.m. Opening Remarks: Samuel Z. Goldhaber, MD
(Moderators: Arthur Sasahara, MD and Samuel Z. Goldhaber, MD)
Prevention: Current Perspectives
9:00 - 9:20 a.m. Patient Advocacy and The United States Congress
Geno Merli, MD
9:20 – 9:25 a.m. Discussion
9:25 – 9:45 a.m. Patient Advocacy: How to Work With UK Parliament
Ajay Kakkar, MD
9:45 – 9:50 a.m. Discussion
9:50 – 10:10 a.m. Prevention of VTE Among Hospitalized Patients:
Human Alerts vs. Electronic Alerts—Are We Better Off Notifying the Attending Physician or the Intern? Samuel Z. Goldhaber, MD
10:10 – 10:15 a.m. Discussion
10:15 - 10:35 a.m. Anticoagulation Armamentarium: Update on Drugs and Mechanisms
- Sudha Parasuraman, MD
10:35 – 10:40 a.m. Discussion
10:40 – 11:00 a.m. Outpatient Treatment of VTE
Sylvia McKean, MD
11:00 – 11:05 a.m. Discussion
11:05 – 11:20 a.m. COFFEE BREAK
Therapeutic Targets and Approaches
11:20 - 11:40 a.m. Hospital Pharmacists and DVT Prevention During Hospitalization and at the Time of Hospital Discharge: A Patient Safety Issue -
John Fanikos, RPh, MBA
11:40 - 11:45 a.m. Discussion
11:45 - 12:05 p.m. Implications of an Out-of-Range INR: Bleeding and Clotting Complications - Elaine Hylek, MD
12:05 - 12:10 p.m. Discussion
12:10 - 12:30 p.m. Warfarin Genetics and Dosing: The New Pharmacogenomic Frontier - Samuel Z. Goldhaber, MD
12:30 - 12:35 p.m. Discussion
12:35 – 12:50 p.m. Substituting Generic Drugs for Brand Name Drugs
Jawed Fareed, PhD
12:50 – 12:55 p.m. Discussion
12:55 - 2:00 p.m. LUNCH
PREVENTION BREAK OUT SESSIONS:
Each session is 45 minutes long and repeated 3 times.
2:00 - 4:45 p.m. Break Out Sessions I / II / III:
Session I: How to Run an Anticoagulation Service
Erin Oliver, PA-C
Mary Kay Kleinschmidt, PA-C
Cheryl Silva, PharmD
Nicole Grasso-Correnti, RN, BSN
Session II: Knowledge Is Power: Patient Advocacy
Samuel Z. Goldhaber, MD – NATF
Ruth B. Morrison, RN – PE SUPPORT GROUP
Mark Jablonski – President, NATT
Michael Hefron – DVT Patient, NATT
Lisa Kory – PE Patient
Session III: VTE Prevention: Making the Evidence Based Guidelines “Come Alive” and Transitioning from Voluntary Adherence to Mandatory Enforcement
Sylvia McKean, MD
John Fanikos, RPh, MBA
|